Gracias Antonio J. — SEC insider filings
SEC reporting owner CIK 1495158. 17 insider filings on record with FilingPulse; latest filed 2026-09-30.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2020-08-20 to 2026-09-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 1 filing — 105 shares, $41,488 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 20 legs across 3 filings — 4,905,747 shares, $332,796,807 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 42.
- Largest priced transaction: sale of 4,000,000 shares @ $30.30 ($121,210,000) in Harmony Biosciences Holdings, Inc., filed 2024-11-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Tesla, Inc. (TSLA) | Director | 4 | 3 legs · 105 sh · $41,488 | 18 legs · 305,747 sh · $193,405,307 | 9 |
| Harmony Biosciences Holdings, Inc. (HRMY) | Director, 10% owner | 10 | — | 2 legs · 4,600,000 sh · $139,391,500 | 15 |
| BITGO HOLDINGS, INC. (BTGO) | 10% owner | 1 | — | — | 16 |
| SPACE EXPLORATION TECHNOLOGIES CORP (SPCX) | Director | 2 | — | — | 2 |
Insider filings — Gracias Antonio J.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-30 | 4/A | SPACE EXPLORATION TECHNOLOGIES CORP (SPCX) | Other (J): 42,790,223 | EDGAR |
| 2026-09-15 | 4 | SPACE EXPLORATION TECHNOLOGIES CORP (SPCX) | Other (J): 42,790,223 | EDGAR |
| 2026-01-27 | 4 | BITGO HOLDINGS, INC. (BTGO) jointly with Valor Digital Investments, LLC, Valor Management L.P. | Conversion (C): 9,201,725 · Conversion (C): 330,277 · Conversion (C): 1,175,180 · Conversion (C): 26,140 · Conversion (C): 649,193 · Conversion (C): 229,502 (derivative) @ $0 · +10 more | EDGAR |
| 2025-09-02 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) jointly with Valor IV Pharma Holdings, LLC, Valor Management L.P., Valor Equity Capital IV LLC, Valor Equity Associates IV L.P., VALOR EQUITY PARTNERS IV L.P., VALOR EQUITY PARTNERS IV-A L.P., VALOR EQUITY PARTNERS IV-B L.P., Sabater Juan A. | Other (J): 6,618,033 | EDGAR |
| 2025-05-16 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) | Grant/award (A): 14,522 (derivative) @ $0 | EDGAR |
| 2024-11-05 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) jointly with Valor IV Pharma Holdings, LLC, Valor Management L.P., Valor Equity Capital IV LLC, Valor Equity Associates IV L.P., VALOR EQUITY PARTNERS IV L.P., VALOR EQUITY PARTNERS IV-A L.P., VALOR EQUITY PARTNERS IV-B L.P., Sabater Juan A. | Sale (S): 4,000,000 @ $30.30 · Sale (S): 600,000 @ $30.30 | EDGAR |
| 2024-05-31 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) | Grant/award (A): 8,870 (derivative) @ $0 | EDGAR |
| 2023-05-26 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) | Grant/award (A): 7,314 (derivative) @ $0 | EDGAR |
| 2022-05-24 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) | Grant/award (A): 6,639 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) | Grant/award (A): 10,144 (derivative) @ $0 | EDGAR |
| 2021-04-05 | 4 | Tesla, Inc. (TSLA) | Purchase (P): 70 @ $377.42 · Purchase (P): 25 @ $375.71 · Purchase (P): 10 @ $567.60 | EDGAR |
| 2021-02-10 | 4 | Tesla, Inc. (TSLA) | Option exercise (M): 97,000 @ $52.38 · Option exercise (M): 53,747 @ $68.56 · Sale (S): 1,930 @ $842.60 · Sale (S): 13,256 @ $843.51 · Sale (S): 22,036 @ $844.37 · Sale (S): 22,122 @ $845.36 · +7 more | EDGAR |
| 2020-12-18 | 4 | Tesla, Inc. (TSLA) | Gift (G): 40,000 @ $0 | EDGAR |
| 2020-10-28 | 4 | Tesla, Inc. (TSLA) | Option exercise (M): 127,500 @ $50.14 · Option exercise (M): 27,500 @ $52.38 · Sale (S): 8,092 @ $421.58 · Sale (S): 1,005 @ $421.94 · Sale (S): 25,863 @ $422.62 · Sale (S): 37,296 @ $423.46 · +7 more | EDGAR |
| 2020-09-04 | 4/A | Harmony Biosciences Holdings, Inc. (HRMY) jointly with Valor IV Pharma Holdings, LLC, Valor Management L.P., Valor Equity Capital IV LLC, Valor Equity Associates IV L.P., VALOR EQUITY PARTNERS IV L.P., VALOR EQUITY PARTNERS IV-A L.P., VALOR EQUITY PARTNERS IV-B L.P., Sabater Juan A. | Conversion (C): 10,139,645 · Conversion (C): 233,052 · Conversion (C): 75,000,000 (derivative) @ $0 · Conversion (C): 1,786,985 (derivative) @ $0 | EDGAR |
| 2020-08-25 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) jointly with Valor IV Pharma Holdings, LLC, Valor Management L.P., Valor Equity Capital IV LLC, Valor Equity Associates IV L.P., VALOR EQUITY PARTNERS IV L.P., VALOR EQUITY PARTNERS IV-A L.P., VALOR EQUITY PARTNERS IV-B L.P., Sabater Juan A. | Conversion (C): 12,080,352 · Conversion (C): 240,668 · Conversion (C): 77,950,712 (derivative) @ $0 · Conversion (C): 1,810,126 (derivative) @ $0 | EDGAR |
| 2020-08-20 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) | Grant/award (A): 12,617 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1495158 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs